Combined ARHGEF6 and Tumor Mutational Burden may serve as a potential biomarker for immunotherapy of lung adenocarcinoma
ARHGEF6 和肿瘤突变负荷联合检测可能作为肺腺癌免疫治疗的潜在生物标志物
期刊:Heliyon
影响因子:3.6
doi:10.1016/j.heliyon.2023.e18501
Tong, Li; Wang, Sichu; Yang, Juanjuan; Zhang, Qing; Gu, Xue; Mo, Taoming; Luo, Yang; Zhang, Chenqian; Zhang, Jianguo; Liu, Yifei